Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
71.3M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
48K
-
Shares change
-
-59.6K
-
Total reported value, excl. options
-
$119K
-
Value change
-
-$211K
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$2.47
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q4 2023
3 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48K shares
of 71.3M outstanding shares and own 0.07% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (4.27M shares), BlackRock Inc. (3.81M shares), VANGUARD GROUP INC (3.74M shares), Capital International Investors (2.35M shares), Logos Global Management LP (2M shares), TANG CAPITAL MANAGEMENT LLC (2M shares), MILLENNIUM MANAGEMENT LLC (1.93M shares), MORGAN STANLEY (1.92M shares), GOLDMAN SACHS GROUP INC (1.36M shares), and Opaleye Management Inc. (1.14M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.